1. Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study. (1st September 2022) Authors: Bai, Xue; Shoushtari, Alexander N.; Betof Warner, Allison; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Quach, Henry T.; Cann, Christopher G.; Zhang, Michael Z.; Pallan, Lalit; Harvey, Catriona; Kim, Michelle S.; Kasumova, Gyulnara; Sharova, Tatyana; Cohen, Justine V.; Law... Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study. (20th May 2022) Authors: Bai, Xue; Shoushtari, Alexander N.; Betof Warner, Allison; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Quach, Henry T.; Cann, Christopher G.; Zhang, Michael Z.; Pallan, Lalit; Harvey, Catriona; Kim, Michelle S.; Kasumova, Gyulnara; Sharova, Tatyana; Cohen, Justine V.; Law... Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient. (30th April 2022) Authors: Kissoonsingh, P.; Sutton, B.; Iqbal, Syed U.; Pallan, Lalit; Steven, Neil; Khoja, L. Other Names: Cives Mauro Academic Editor. Journal: Case reports in oncological medicine Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series. Issue 6 (23rd September 2022) Authors: Smith, Jessica Louise; Menzies, Alexander M.; Cohen, Justine V.; Mut-Lloret, Margarida; Ozgun, Alpaslan; Spain, Lavinia; Park, John; Quach, Henry T.; Pallan, Lalit; McQuade, Jennifer; Feng, Sophie; Sandhu, Shahneen; Atkinson, Victoria; Tsai, Katy; Long, Georgina V.; Larkin, James; Eroglu, Zeynep;... Journal: Melanoma research Issue: Volume 32:Issue 6(2022) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti–PD-1 therapy. (August 2021) Authors: Hepner, Adriana; Atkinson, Victoria G.; Larkin, James; Burrell, Rebecca A.; Carlino, Matteo S.; Johnson, Douglas B.; Zimmer, Lisa; Tsai, Katy K.; Klein, Oliver; Lo, Serigne N.; Haydon, Andrew; Bhave, Prachi; Lyle, Megan; Pallan, Lalit; Pires da Silva, Ines; Gerard, Camille; Michielin, Olivier; Lo... Journal: European journal of cancer Issue: Volume 153(2021) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases – A multicenter cohort study. (July 2022) Authors: Holmberg, Carl-Jacob; Ny, Lars; Hieken, Tina J.; Block, Matthew S.; Carr, Michael J.; Sondak, Vernon K.; Örtenwall, Christoffer; Katsarelias, Dimitrios; Dimitriou, Florentia; Menzies, Alexander M.; Saw, Robyn PM.; Rogiers, Aljosja; Straker, Richard J.; Karakousis, Giorgos; Applewaite, Rona; Palla... Journal: European journal of cancer Issue: Volume 169(2022) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗